Adherence and Quality of Life in Adult Patients With Haemophilia A, Haemophilia B and Von Willebrand Disease: A National Cross‐Sectional Survey
European Journal of Haematology · 2025
DOI: 10.1111/ejh.14324 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2025. Verfasst von Cecilie Maria Lüthje Clausen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Haemophilia Centre, Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Quality of Life, von Willebrand Diseases, Hemophilia B, Hemophilia A. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Denmark, Department of Haematology, Christian Medical College, Vellore.
Abstract (Originalsprache)
Background
New treatments for patients with bleeding disorders (PWB) have emerged, including products with extended half‐life and subcutaneous administration. These less frequent treatments can potentially enhance quality of life (QoL), but adherence becomes critically important.
Aim
To investigate adherence and QoL among PWB and explore the correlation between treatment adherence and QoL in adult patients with haemophilia A (HA), haemophilia B (HB) and Von Willebrand disease (vWD) in Denmark.
Method
This survey used disease‐specific patient‐reported questionnaires: Veritas‐PRO and Veritas‐PRN to measure adherence, and Haemo‐A‐QoL and VWD‐QoL to assess QoL.
Results
Responses were obtained from 149 patients with HA, 32 with HB and 118 with vWD. Adherence was reported by 87.1% of patients on prophylaxis and 71.2% of patients treated on demand, according to Veritas‐PRO and Veritas‐PRN cut‐off scores. High QoL was generally reported, decreasing with age in HA and HB, but not in vWD.
Conclusion
Danish patients with HA, HB and vWD reported high QoL and high adherence to prescribed treatments. There was no correlation between treatment adherence and QoL among the different patient groups. These findings highlight the need for further research to better understand adherence behaviours and identify opportunities to further improve QoL in PWB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Copenhagen Haemophilia Centre, Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Mathematical Sciences, Data Science Lab, University of Copenhagen, Copenhagen, Denmark.
- Danish Cancer Institute, Copenhagen, Denmark.
- Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Cecilie Maria Lüthje Clausen
Förderung
- Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Denmark
- Department of Haematology, Christian Medical College, Vellore
Zitieren
APA
Clausen, C. M. L., Funding, E., Tolver, A., & Jarden, M. (2025). Adherence and Quality of Life in Adult Patients With Haemophilia A, Haemophilia B and Von Willebrand Disease: A National Cross‐Sectional Survey. European Journal of Haematology. https://doi.org/10.1111/ejh.14324
Vancouver
Clausen CML, Funding E, Tolver A, Jarden M. Adherence and Quality of Life in Adult Patients With Haemophilia A, Haemophilia B and Von Willebrand Disease: A National Cross‐Sectional Survey. European Journal of Haematology. 2025. doi:10.1111/ejh.14324
BibTeX
@article{Clausen2025,
author = {Clausen, Cecilie Maria Lüthje and Funding, Eva and Tolver, Anders and Jarden, Mary},
title = {Adherence and Quality of Life in Adult Patients With Haemophilia A, Haemophilia B and Von Willebrand Disease: A National Cross‐Sectional Survey},
journal = {European Journal of Haematology},
year = {2025},
doi = {10.1111/ejh.14324}
}
EUVIMED